While the immune infiltration analysis in our study showed a higher infiltration of CD8+ T-cells in the high-risk group, further analysis revealed that these patients might have higher levels of exhausted CD8+ T-cells due to chronic activation, rendering the poorer prognosis in the high-risk group and inability to mount an effective anti-tumor immune response. The gene discussed is CD8A; the disease is neoplasm.